Discover open access scientific publications

Search, annotate, share and cite publications

Publications by D.M. Pardoll

The Immunodynamics of Myeloid-Derived Suppressor Cell and Monocyte Populations in the Peripheral Blood in Patients With Newly Diagnosed Glioblastoma Undergoing Adjuvant Temozolomide and Radiation Therapy

International Journal of Radiation Oncology Biology Physics

English

Bioactivity of Autologous Irradiated Renal Cell Carcinoma Vaccines Generated by Ex Vivo Granulocyte-Macrophage Colony-Stimulating Factor Gene Transfer

Journal of Urology

Urology

1998

English

Related publications

Late Radiation Outcomes of Patients With Newly Diagnosed Glioblastoma Treated With Accelerated Hyperfractionated Radiotherapy and Temozolomide

Turk Onkoloji Dergisi

Oncology

2019

English

Phase II Study of Bevacizumab Plus Temozolomide During and After Radiation Therapy for Patients With Newly Diagnosed Glioblastoma Multiforme

Journal of Clinical Oncology

English

Recurrence Pattern After Temozolomide Concomitant With and Adjuvant to Radiotherapy in Newly Diagnosed Patients With Glioblastoma: Correlation WithMGMTPromoter Methylation Status

Journal of Clinical Oncology

English

Comparison of ADC Metrics and Their Association With Outcome for Patients With Newly Diagnosed Glioblastoma Being Treated With Radiation Therapy, Temozolomide, Erlotinib and Bevacizumab

Journal of Neuro-Oncology

English

Myeloid-Derived Suppressor Cells in Transplantation: The Dawn of Cell Therapy

Journal of Translational Medicine

English

Using Temozolomide in Newly Diagnosed Glioblastoma Multiforme – A Single-Centre Experience

Wspolczesna Onkologia

English

Controversies in the Treatment of Elderly Patients With Newly Diagnosed Glioblastoma

Journal of the National Comprehensive Cancer Network : JNCCN

Medicine

Oncology

2013

English

Phase 1 Lead-In to a Phase 2 Factorial Study of Temozolomide Plus Memantine, Mefloquine, and Metformin as Postradiation Adjuvant Therapy for Newly Diagnosed Glioblastoma

English

Short-Course Radiation Plus Temozolomide in Elderly Patients With Glioblastoma

New England Journal of Medicine

Medicine

2017

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by D.M. Pardoll

The Immunodynamics of Myeloid-Derived Suppressor Cell and Monocyte Populations in the Peripheral Blood in Patients With Newly Diagnosed Glioblastoma Undergoing Adjuvant Temozolomide and Radiation Therapy

Bioactivity of Autologous Irradiated Renal Cell Carcinoma Vaccines Generated by Ex Vivo Granulocyte-Macrophage Colony-Stimulating Factor Gene Transfer

Related publications

Late Radiation Outcomes of Patients With Newly Diagnosed Glioblastoma Treated With Accelerated Hyperfractionated Radiotherapy and Temozolomide

Phase II Study of Bevacizumab Plus Temozolomide During and After Radiation Therapy for Patients With Newly Diagnosed Glioblastoma Multiforme

Recurrence Pattern After Temozolomide Concomitant With and Adjuvant to Radiotherapy in Newly Diagnosed Patients With Glioblastoma: Correlation WithMGMTPromoter Methylation Status

Comparison of ADC Metrics and Their Association With Outcome for Patients With Newly Diagnosed Glioblastoma Being Treated With Radiation Therapy, Temozolomide, Erlotinib and Bevacizumab

Myeloid-Derived Suppressor Cells in Transplantation: The Dawn of Cell Therapy

Using Temozolomide in Newly Diagnosed Glioblastoma Multiforme – A Single-Centre Experience

Controversies in the Treatment of Elderly Patients With Newly Diagnosed Glioblastoma

Phase 1 Lead-In to a Phase 2 Factorial Study of Temozolomide Plus Memantine, Mefloquine, and Metformin as Postradiation Adjuvant Therapy for Newly Diagnosed Glioblastoma

Short-Course Radiation Plus Temozolomide in Elderly Patients With Glioblastoma